U.S. health officials are advising a group of citizens recently exposed to the Ebola virus in the Democratic Republic of the Congo to wait for peer-reviewed literature before assuming their symptoms are causally linked to the pathogen. Authorities stressed the importance of ruling out confounding variables before rushing to a diagnosis.
According to preliminary reports first highlighted by STAT, an unspecified number of U.S. citizens are believed to have come into contact with suspected Ebola cases during the country’s latest outbreak. However, representatives from the Centers for Disease Control and Prevention were quick to emphasize Tuesday that being in direct physical proximity to a patient with an active Zaire ebolavirus infection is merely an observational data point, and falls well short of the gold standard of a randomized controlled trial.
While we are seeing a robust, statistically significant association between these individuals standing in a high-risk contagion zone and their subsequent desire to dictate a last will and testament, we must be careful not to conflate proximity with pathology.
The exposed cohort presents significant methodological challenges for researchers attempting to draw definitive conclusions about their potential liquefaction. Officials noted that early-onset symptoms such as sudden fever, severe muscle pain, and unexplained multi-organ hemorrhaging could just as easily be attributed to standard international travel fatigue, localized dehydration, or an undisclosed preexisting condition, rendering any immediate diagnosis strictly provisional.
A pre-print editorial slated for next month’s issue of The Lancet suggests that panicking about the virus's historical 50-to-90 percent mortality rate often fails to account for shifting confidence intervals. Furthermore, the World Health Organization has disclosed that several field researchers tracking the outbreak have previously received travel grants from therapeutic developers, necessitating a baseline level of skepticism regarding any aggressive claims that the virus is currently destroying the patients' endothelial cells.
Until double-blind, placebo-controlled studies can definitively prove that the viral RNA currently replicating in the Americans' bloodstreams is solely responsible for their rapidly deteriorating condition, the CDC recommends the exposed individuals simply monitor their symptoms, hydrate frequently, and maintain a healthy, evidence-based doubt about their own impending mortality.